# Amitiza

NDC: 64764-080
Generic name: lubiprostone
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, GELATIN COATED
Routes: ORAL
Marketing started: 20060131
Marketing ended: 20270331
FDA application: NDA021908

## Active ingredients

- LUBIPROSTONE: 8 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64764-080"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-080
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d474ac6a-444d-4aa6-9986-24be6fcf811d